Medicine and Dentistry
Acetylsalicylic Acid
14%
Anakinra
14%
Artificial Respiration
20%
Atypical Hyperplasia
14%
Azithromycin
14%
Biological Marker
14%
Breast Cancer
14%
Cancer Cell
14%
Care Group
14%
Cerebral Sinus Thrombosis
14%
Corticosteroid
5%
COVID-19
100%
COVID-19 Therapy
71%
Dexamethasone
6%
Diseases
5%
Drug Megadose
14%
Empagliflozin
14%
Endometrial Cancer
14%
Frontotemporal Lobar Degeneration
14%
Fumaric Acid Dimethyl Ester
14%
Human Epididymis Protein 4
14%
Hypoxia
11%
Immunoglobulin
14%
In Vitro
14%
Infusion
5%
Intention-to-Treat Analysis
10%
Levonorgestrel
14%
Low Drug Dose
6%
Methylprednisolone
9%
Monoclonal Antibody
7%
Motor Neuron Disease
14%
Neoplasm
14%
Omicron Coronavirus Variant
5%
Overall Survival
5%
Paclitaxel
14%
Progression Free Survival
5%
Proopiomelanocortin
14%
Serositis
14%
Severe Acute Respiratory Syndrome Coronavirus 2
31%
Small Cell Lung Cancer
14%
Tau
14%
TDP 43 Proteinopathy
14%
Tocilizumab
28%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
14%
Azithromycin
14%
Baricitinib
14%
Biological Marker
14%
Breast Cancer
14%
Empagliflozin
14%
Endometrium Cancer
28%
Endometrium Carcinoma
7%
Febrile Neutropenia
7%
Fumaric Acid Dimethyl Ester
14%
Human Epididymis Protein 4
14%
Hyperplasia
14%
Immunotherapy
28%
Inflammation
5%
Janus Kinase Inhibitor
7%
Levonorgestrel
14%
Non Small Cell Lung Cancer
28%
Overall Survival
6%
Paclitaxel
14%
Progression Free Survival
15%
SARS Coronavirus
14%
Nursing and Health Professions
Artificial Respiration
23%
Azithromycin
14%
Baricitinib
14%
Dexamethasone
6%
Drug Megadose
14%
Empagliflozin
14%
Health Care Quality
16%
Hypoxia
6%
Intention to Treat Analysis
7%
Janus Kinase Inhibitor
7%
Low Drug Dose
6%
Meta Analysis
14%
National Health Organization
9%
Randomization
7%
Rate Ratio
19%